AI assistant
Sending…
RESMED INC — Director's Dealing 2018
Dec 3, 2018
30071_dirs_2018-12-03_44b56e90-c233-4b90-aeb4-74016680440a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-11-30
Reporting Person: Hollingshead James (President, Americas)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-30 | ResMed Common Stock | M | 9168 | $43.63 | Acquired | 84289 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-11-30 | Resmed Stock Option Plan | $43.63 | M | 9168 | Disposed | 2020-03-01 | ResMed Commmon Stock (9168) | Direct |
Footnotes
F1: Represents date options first become exercisable. Options vest 1/3 annually on the grant anniversary.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29